ABSTRACT Background: Despite the contribution of dairy foods to total dietary saturated fat intake, available data indicate that dairy consumption may lower the risk of cardiovascular disease. Objective: The objective of this study was to investigate the relation between consumption of milk, cheese, and yogurt and common carotid artery intima-media thickness (CCA-IMT) in a cohort of elderly women. Design: Dairy consumption was assessed with a validated foodfrequency questionnaire in 1080 participants randomly selected from ambulant white women aged .70 y living in Perth, Western Australia. CCA-IMT was assessed by using B-mode carotid ultrasound 3 y later. Cardiovascular disease risk factors, including serum lipids and blood pressure, were assessed at baseline. Results: Total dairy product, milk, and cheese consumption was not associated with CCA-IMT (P . 0.05), whereas yogurt consumption was negatively associated with CCA-IMT (unadjusted standardized b = 20.081, P = 0.008; baseline risk factor-adjusted standardized b = 20.075, P = 0.015). Participants who consumed .100 g yogurt/d had a significantly lower CCA-IMT than did participants with lower consumption (unadjusted = 20.024 mm, P = 0.002). This relation remained significant after adjustment for baseline, dietary, and lifestyle risk factors (multivariable analysis = 20.023 mm, P = 0.003). Conclusion: Increased consumption of yogurt, but not of other dairy products, is associated with a lower CCA-IMT, independent of other risk factors.
INTRODUCTION
Elevated common carotid artery intima-media thickness (CCA-IMT) has been shown to be predictive of stroke, coronary deaths, and coronary events, including myocardial infarction (1) (2) (3) . Recognized risk factors for cardiovascular disease, which have been identified as contributing to CCA-IMT, include lifestyle, blood pressure, and serum lipids (4, 5) ; however, investigations evaluating the link between the intake of whole foods and CCA-IMT are scarce.
Although the World Health Organization recommends limiting the intake of cholesterol, myristic acid, and palmitic acid from dairy fat sources to achieve reductions in cardiovascular disease risk (6) , beneficial associations between dairy consumption and cardiovascular disease risk factors and outcomes have been identified in several studies (7, 8) . As far back as the early 1970s, benefits of regular consumption of fermented dairy products on atherosclerotic vascular disease (ASVD) and cardiovascular health have been suggested (9) , with evidence of beneficial effects in randomized control trials (10) (11) (12) , including a potential reduction in arterial stiffness associated with formulated fermented milk products containing tripeptides (13, 14) .
This study aimed to investigate the association between intake of different dairy sources and CCA-IMT in a population-based study of older women from the Calcium Intake Fracture Outcome Study (CAIFOS) cohort. Potential mediators of ASVD were also explored by assessing the relations of dairy consumption with recognized risk factors for cardiovascular disease.
SUBJECTS AND METHODS

Participants
Participants were recruited in 1998 to a 5-y prospective, randomized, controlled trial of oral calcium supplements to prevent osteoporotic fractures (15) . Participants were recruited from the Western Australian general population of women aged .70 y by mail with the use of the electoral roll-a requirement of citizenship. More than 99% of Australians of this age are registered on the roll. Of the 5586 women who responded to a letter inviting participation, 1510 women were willing and eligible.
Participants were ambulant and did not have any medical conditions likely to influence 5-y survival. They were excluded if they were receiving bone-active agents, including hormone-replacement therapy. From this group 1500 women were recruited; of these, 1080 had complete food-frequency questionnaire and carotid ultrasound data. Participants were similar in terms of disease burden and pharmaceutical consumption to the whole population of this age, but they were more likely to be from higher socioeconomic groups (16) . Informed consent was obtained, and the Human Ethics Committee of the University of Western Australia approved the study.
Baseline vascular disease risk assessment
The participants provided their previous medical history, and current medications were verified by their general practitioner. These data were coded by using the International Classification of Primary Care-Plus (ICPC-Plus) method (17) , which allowed aggregation of different terms for similar pathologic entities as defined by the ICD-10 coding system. These data were then used to determine the presence of preexisting vascular disease, including ischemic heart disease, heart failure, arrhythmia, stroke (excluding hemorrhagic stroke), and peripheral vascular disease (K74000-99011). The presence of baseline vascular disease risk factors were recorded, including preexisting diabetes (T89001-90009). Smoking status was coded as nonsmoker or ex-smoker/current smoker if the subjects had smoked .1 cigarette/d for .3 mo at any time in their life. Cardiovascular medications included b-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, and antiplatelet agents. Physical activity was assessed by using a previously validated questionnaire in which participants reported the time in hours of involvement in up to 4 sports, recreational activities, and other forms of regular physical activity, including walking, that were undertaken in the past 3 mo. Energy expenditure (kJ/d) for these activities was calculated with the use of published energy costs (18, 19) .
Assessment of dairy consumption
A validated semiquantitative food-frequency questionnaire developed by the Anti-Cancer Council of Victoria was used to assess baseline dietary intake, including milk, cheese, and yogurt consumption (20) . The process of collection was identical, whereby a research assistant supervised the completion of the questionnaire in small groups. Food models, cups, spoons, and charts for frequency were provided. Energy and nutrient intakes were estimated based on frequency of consumption and an overall estimate of usual portion size (21) . Frequency of consumption was represented as servings per day; specifically, they reported an average consumption of milk, cheese, and yogurt over the preceding 12 mo, using 200 g as the yogurt serving size, 250 g as the milk serving size, and 30 g to represent the average cheese serve size.
Clinical measurements
Common carotid artery intima-media thickness and focal carotid plaques were measured in 2001 (year 3) by using a B-mode carotid ultrasound machine (8.0-MHz linear array transducer fitted to an Acuson Sequoia 512 ultrasound machine) and a standard image-acquisition protocol (22) . The far walls of the distal 2 cm of the left and right common carotid arteries were examined, and images were taken from 3 different angles (anterolateral, lateral, and posterolateral) to account for asymmetrical wall thickening. End-diastolic images were recorded and a semiautomated edgedetection software program was used for image analysis. The same technician performed off-line analysis of all images. The mean, maximum, minimum, and SD of measurements for each of the 3 views on both sides were collected. The CCA-IMT from each of the 6 images was averaged to give an overall mean CCA-IMT. Plaque was defined as a clearly identified area of focal increased thickness (1 mm) of the intima-media layer.
A short-term precision study was undertaken by using the same combination of technicians. Twenty nontrial subjects were selected, and repeat CCA-IMT measurements were made between 0 and 31 d apart (mean: 10.3 d). The CV for the repeat measures, calculated by using the root-mean-square method, was 5.98% (23) .
Baseline weight was assessed by using digital scales while the participants were wearing light clothes and no shoes. Baseline height was assessed by using a stadiometer, and body mass index (BMI) was calculated in kg/m 2 . Serum lipid profiles were obtained for 1002 (92.8%) of the participants at baseline. Total cholesterol, HDL cholesterol, and triglyceride concentrations were measured by using a Hitachi 917 auto analyzer (Roche Diagnostics, Mannheim, Germany). LDL cholesterol was calculated by using Friedewald's method (24) . Blood pressure was measured on the right arm with a mercury column manometer by using an adult cuff after the patient had been seated and rested for 5 min; the average of 3 such measurements was obtained.
Statistical analyses
Before the statistical analysis began, a prespecified analytic protocol was produced. Baseline ASVD risk factors were tested for differences by using ANOVA or chi-square test where appropriate. The relations between total dairy product, milk, cheese, and yogurt consumption and CCA-IMT, HDL cholesterol, LDL cholesterol, and systolic and diastolic blood pressures were examined in regression analysis using unadjusted, age-adjusted, and baseline risk factor-adjusted models. The baseline risk factoradjusted model included age, BMI, energy intake, energy expended in physical activity, use of vascular medication, diabetes, and history of both vascular disease and smoking (4).
Yogurt consumption was then dichotomized into 3 groups for further analysis by analysis of variance (ANOVA) with Tukey's test or a chi-square test where appropriate. Post hoc comparisons were only made after the main effect of the factor was found to be significant in the ANOVA in the age-adjusted and multivariable analysis. Stepwise linear regression was then used to identify covariates which were associated with CCA-IMT. These covariates were then included in the ANCOVA model.
Atherosclerotic plaque odds ratios (ORs) and 95% CIs were obtained by using binary logistic regression. The data were analyzed by using SPSS (version 15; SPSS Inc, Chicago, IL) and SAS (version 9; SAS Institute Inc, Chicago, IL).
RESULTS
The baseline characteristics of participants are shown in Table  1 Dairy product intake and CCA-IMT High yogurt consumption, but not milk or cheese consumption, was associated with lower CCA-IMT and higher HDL cholesterol ( Table 2) . After adjustment for prespecified baseline risk factors, the effect on HDL cholesterol was not significant. No associations were found with other cardiovascular disease risk factors, including LDL cholesterol and systolic and diastolic blood pressures.
Total dairy intake was not significantly associated with CCA-IMT by linear regression in unadjusted or adjusted analyses. However total dairy intake was significantly associated with HDL cholesterol in unadjusted (b = 0.073, P = 0.025) and adjusted (b = 0.069, P = 0.032) analyses.
Yogurt and CCA-IMT
The effect of yogurt was explored further by dividing the participants into 3 groups: low (,100 g/d), moderate (100 to ,200 g/d), and high (200 g/d) yogurt consumption. In an unadjusted analysis, the CCA-IMT of moderate-and high-yogurtconsuming participants was 3.1% and 3.0%, respectively, which was lower than in participants with a low yogurt intake ( Figure  1 ).
Participants with yogurt consumption 100 g/d (moderate and high yogurt consumers) had a significantly lower CCA-IMT than did those with yogurt consumption of ,100 g/d (unadjusted mean difference = 20.024 mm, P = 0.002; multivariable-analysis mean difference = 20.023 mm, P = 0.003). Another cardiovascular disease risk factor selected in the preplanned analysis that was associated with yogurt consumption was HDL cholesterol ( Table 3) . High yogurt consumers also consumed significantly Table 4) . The relation between yogurt consumption and CCA-IMT was examined in stepwise linear regression models to account for potential covariance of independent variables. The multivariable candidate variables included age, BMI, energy intake, energy expended in physical activity, use of vascular medication, diabetes, history of both vascular disease and smoking, HDL cholesterol, and consumption of protein, carbohydrate, fiber, fish, vitamin E, and fruit at baseline. The results of ANCOVA (Table 5) showed that, in addition to yogurt intake (P = 0.019), which remained highly significant, the most parsimonious model consisted of age (P = 0.002), ever smoked (P = 0.033), and energy expended in physical activity (P = 0.044). Dividing the participants into tertiles of yogurt intake (lower tertile: 0-4 g/d; middle tertile: 4-100 g/d; upper tertile: 100-600 g/d) produced similarly significant relations between yogurt intake and CCA-IMT (data not shown).
Carotid atherosclerotic plaques
The presence of carotid atherosclerotic plaques was not significantly different between yogurt consumption groups (data not shown).
DISCUSSION
Yogurt consumption was negatively associated with CCA-IMT in this cohort of older women, whereas total dairy product, milk, and cheese consumption showed no significant association. These findings support those of the prospective study by Tavani et al (25) , who found that yogurt consumption, but not milk or cheese consumption, was associated with a lower risk of acute myocardial infarction-a clinical outcome of ASVD associated with CCA-IMT (1).
Consumption of .100 g yogurt/d was associated with a significantly lower CCA-IMT. This relation was sufficiently robust to remain after adjustment for identified baseline, dietary, and lifestyle risk factors. Compared with subjects with low yogurt consumption, those with moderate yogurt consumption had a 3.1% lower CCA-IMT (0.024-mm difference) and no additional benefit of higher yogurt intake was observed. This difference was likely to be of clinical significance, because the long-term epidemiology cohort study by Hodis et al (2) found that a 0.03-mm increase in CCA-IMT had a relative risk of a coronary event of 3.1.
A controlled trial by Kiessling et al (26) found that daily yogurt consumption increased HDL-cholesterol concentrations. This finding is consistent with the observed positive association between yogurt consumption and HDL cholesterol in the current study, which indicated that the food-frequency questionnaire was sufficiently accurate to detect this association.
The inclusion of HDL cholesterol in linear regression models did not account for the relation between yogurt consumption and CCA-IMT. Although this may have been due to a type 2 statistical error, another possibility is that the association between yogurt consumption and CCA-IMT may be mediated by other mechanisms in addition to an elevated HDL cholesterol. However, because HDL cholesterol has been found to be associated with bulbar intima-media thickness, but not with CCA-IMT (3), it is possible that HDL cholesterol does not mediate the relation between yogurt consumption and CCA-IMT.
Although an association between yogurt consumption and HDL cholesterol was identified, this did not extend to LDL cholesterol, triglyceride, or blood pressure. This is surprising in view of the fact that antihypertensive compounds in the probiotic species Lactobacillus casei have been identified (27) , and fermented milk has been found to significantly lower plasma triglycerides and systolic blood pressure in healthy men (28) . No significant association between yogurt consumption and LDL cholesterol was found, which is consistent with the findings of Kiessling et al (26) , who found that despite yogurt consumption improving HDLcholesterol concentrations, no significant effect on total cholesterol or LDL-cholesterol concentrations was found.
Note that the causality of the relation between yogurt consumption and CCA-IMT cannot be established because of the observational nature of the study. Also, despite the inclusion of baseline, dietary, and lifestyle risk factors into statistical models, residual or unmeasured confounders cannot be ruled out. Although most yogurt products consumed in Australia contain probiotic cultures of Lactobacillus acidophilus, Bifidobacteria, and L. casei (29) , identification of causality is further limited by the complexity of yogurt composition, particularly the concentration and species of viable probiotic bacteria. However, the strength of the association was such that, despite these factors, the association remained significant even after adjustment for baseline, dietary, and lifestyle risk factors.
In this cohort of elderly women, yogurt intake was beneficially associated with CCA-IMT, which suggests that increased consumption of yogurt, but not of other dairy products, may prevent thickening of the common carotid artery intima-media. Because the relation remains significant after adjustment for known risk factors, these results do not appear to be due to co-correlation with other baseline, dietary, and lifestyle risk factors. Through its role in reducing CCA-IMT, prolonged daily yogurt consumption of 100 g/d may play a role in stroke and atherosclerosis prevention. Ultimately, to make public health recommendations regarding yogurt intake, further observational and clinical trials are necessary to establish whether moderate-to-high yogurt consumption can prevent or even ameliorate intima-media thickening of the common carotid artery.
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